Unveiling Lucrative Segments in the Peptide Antibiotics Market 2024-2033| Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Theravance Biopharma Inc., Merck & Co. Inc.

Overview and Scope
Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning.

Sizing and Forecast
The peptide antibiotics market size has grown rapidly in recent years. It will grow from $4.79 billion in 2023 to $5.31 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%.  The  growth in the historic period can be attributed to discovery and development of peptide antibiotics, increased antibiotic resistance, rise in the incidence of infectious diseases, advances in peptide synthesis technologies, growth of the pharmaceutical industry.

The peptide antibiotics market size is expected to see strong growth in the next few years. It will grow to $7.78 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%.  The growth in the forecast period can be attributed to emphasis on novel antibiotics development, increasing global incidence of antibiotic-resistant infections, expansion of research and development in antimicrobial peptides, regulatory support for new antibiotic approvals. Major trends in the forecast period include exploration of natural sources for antimicrobial peptides, application of peptide antibiotics in animal health, focus on peptide engineering for enhanced efficacy, development of combination peptide antibiotics, integration of ai and machine learning in peptide antibiotic discovery.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Segmentation & Regional Insights
The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-rRibosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP/VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

North America was the largest region in the peptide antibiotics market in 2023. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Major Driver Impacting Market Growth
The increase in the prevalence of various infectious diseases is expected to propel the growth of the peptide antibiotics market. Infectious diseases are illnesses caused by harmful micro-organisms such as bacteria, fungi, parasites, and others. The major reasons for the rise in infectious diseases are rapid urbanization, climate change, increasing risk of disease emergence, and others, which have increased the demand for peptide antibiotics. Peptide antibiotics physically rupture the cell membranes and underpin the antibacterial activity. For instance, in July 2022, according to the Australian Institute of Health and Welfare, an organization that provides data and statistics about Australia’s welfare and health, the cases of notifiable infectious diseases in Australia grew from 2.89 million cases in 2020 to 7.02 million cases in 2021. It shows a significant growth in the total number of cases of infectious diseases. Therefore, the increase in the incidence of infectious is driving the peptide antibiotics market growth.

Key Industry Players
Major companies operating in the peptide antibiotics market report are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Theravance Biopharma Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, AuroMedics Pharma LLC, EnBiotix Inc., Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, AdvaCare Pharma, Allecra Therapeutics GmbH, AmpliPhi Biosciences Corporation, Antabio, Arsanis Inc., Basilea Pharmaceutica Ltd., BioVersys AG, Curis Inc.

The peptide antibiotics market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

 

Related Reports:
https://topprnews.com/employment-screening-services-market-report/
https://topprnews.com/external-cloud-automotive-cyber-security-services-market-analysis/
https://topprnews.com/fraud-detection-and-prevention-market-trends/
https://topprnews.com/hair-accessories-market-insights/
https://goodprnews.com/employment-screening-services-market-size/
https://goodprnews.com/xternal-cloud-automotive-cyber-security-services-market-insights/
https://goodprnews.com/fraud-detection-and-prevention-market-trends/
https://goodprnews.com/hair-accessories-market-size/

 

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model